Search

Mei Xiao Yu

from Oakland, CA
Age ~66
Get Report
Also known as:
Mei X Yu, Mei Siao Yu, Mei Xyu
Phone and address:
3724 35Th Ave, Oakland, CA 94619
(510) 336-9249
Related to:
Pui P YuJason Yi Yu, 54Kelvin F Zeng, 51Zhu C Yu, 67Kam H YuTony Yu, 34Yi C Yu, 59Ya Fang Hsieh, 54
Connected to:
Abigail M Yu, 43Adeline Y Yu, 40Ai Yu, 64Aimy Yu, 30Aiping A Yu, 71Alisa Yu, 34Allen Yu, 30Angelia W Yu, 74Angelita T Yu, 68Anna Yu, 56

Mei Yu Phones & Addresses

  • 3724 35Th Ave, Oakland, CA 94619 (510) 336-9249
  • San Francisco, CA

Resumes

Resumes

Mei Yu Photo 1

Mei Yu San Francisco, CA

View page
Work:
Satish Angra
Silver Spring, MD
2010 to Oct 2013
Billing Clerk / Office Administrative
Frekko Primary Care
Gaithersburg, MD
2006 to Aug 2013
PRN LPN
Jew & Jew Medical
San Francisco, CA
2001 to 2006
Medical Billing Clerk and Medical Assistant
Education:
City College of San Francisco
May 2006
Associates in Nursing

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mei Yu
Marketing Executive
Bechtel National, Inc.
Engineering Services
50 Beale St, San Francisco, CA 94105
Mei Yu
Treasurer
Befut Corporation
Mei Yu
Office Manager
Sumui Kuo MD
Medical Doctor's Office · Pediatrician
728 Pacific Ave, San Francisco, CA 94133
(415) 393-6500
Mei Yuet Yu
716 Jackson Street, LLC
716 Jackson St, San Francisco, CA 94133
Mei Chu Yu
INTERNATIONAL TECH CORPORATION, LLC
Mei Yuet Yu
President
Dick Lee Pastry Shop
Ret Pastry Shop
777 Jackson St, San Francisco, CA 94133
716 Jackson St, San Francisco, CA 94133
(415) 397-0788, (415) 397-1236
Mei Kwan Yu
President
C & S SEWING COMPANY, INC
1161 Msn St, San Francisco, CA 94103
Mei Hsia Yu
President
ADAPNET TECHNOLOGY, INC
4700 Warm Spg Blvd STE 293, Fremont, CA 94539
Mei Yu
Marketing Executive
Bechtel National, Inc.
Engineering Services
50 Beale St, San Francisco, CA 94105

Publications

Us Patents

Preferential Inhibition Of Presenilin-1

View page
US Patent:
20080045499, Feb 21, 2008
Filed:
Feb 6, 2007
Appl. No.:
11/671926
Inventors:
Byron Zhao - Sugar Land TX, US
Mei Yu - San Francisco CA, US
Guriqbal Basi - Palo Alto CA, US
International Classification:
A61K 31/18
A61K 31/55
A61P 25/28
C07C 311/16
C07D 223/10
C07D 401/12
C07K 14/00
C07K 16/00
C12Q 1/02
US Classification:
514212030, 435029000, 514212040, 514604000, 514789000, 530324000, 530387900, 530389100, 540522000, 540524000, 540527000, 564092000
Abstract:
The invention provides methods for determining whether an agent preferentially inhibits Presenilin-1-comprised γ-secretase relative to Presenilin-2-comprised γ-secretase. The invention also provides agents that preferentially inhibit Presenilin-1-comprised γ-secretase relative to Presenilin-2-comprised γ-secretase, pharmaceutical compositions comprising such compounds, and methods of treating Alzheimer's disease using such compounds. The invention also discloses that the N-terminal domain of presenilin-1 and -2 determines the difference in the production of Aβ by PS1-comprised and PS2-comprised gamma secretases. This finding identified the structural determinant for the observed difference in the production of Aβ by PS1-comprised and PS2-comprised gamma secretases. Such structural determinant was not identified before. This invention also provides a method for determining whether an agent specifically binds the N terminus of PS1. The invention further provides for methods of treatment of Alzheimer's Disease by administration of an effective dose of an agent which specifically binds PS1, thereby inhibiting PS1 activity.

Hcv Genotype 3 Replicons

View page
US Patent:
20130052633, Feb 28, 2013
Filed:
Jul 5, 2012
Appl. No.:
13/542551
Inventors:
Guofeng Cheng - Foster City CA, US
Hongmei Mo - Palo Alto CA, US
Simin Xu - Palo Alto CA, US
Mei Yu - San Francisco CA, US
Amoreena Corsa - San Francisco CA, US
Assignee:
Gilead Sciences, Inc. - San Francisco CA
International Classification:
C12N 15/63
C12Q 1/70
C07K 14/18
C07K 16/10
C12N 15/40
C12N 5/09
US Classification:
435 5, 4353201, 536 2372, 435370, 530350, 5303894
Abstract:
Replicons of genotype 3 of hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 3 replicons and methods of using these replicons to screen antiviral agents are also provided.

Neuroprotective Effects Of Atf6

View page
US Patent:
20060246037, Nov 2, 2006
Filed:
Jul 30, 2004
Appl. No.:
10/575457
Inventors:
Bryon Zhao - Millbrae CA, US
Mei Yu - San Francisco CA, US
International Classification:
A61K 48/00
A61K 31/045
US Classification:
424093200, 514044000, 514738000
Abstract:
The present invention relates to methods for preventing cell death in a subject and the application of these methods for treating neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, etc. In one embodiment of the invention, a method for preventing cell death may comprise effecting overexpression of an active form of ATF6 in the cell.

Methods Of Treating Hepatitis B Virus

View page
US Patent:
20180042905, Feb 15, 2018
Filed:
Aug 29, 2017
Appl. No.:
15/689985
Inventors:
- Foster City CA, US
Todd Appleby - San Francisco CA, US
Gabriel Birkus - San Francisco CA, US
Guofeng Cheng - Foster City CA, US
David Dornan - Burlingame CA, US
Tetsuya Kobayashi - Pleasanton CA, US
Christopher Charles Mello - Sunnyvale CA, US
Uli Schmitz - Foster City CA, US
Madeleine Willkom - Foster City CA, US
Mei Yu - Foster City CA, US
International Classification:
A61K 31/44
A61K 45/06
Abstract:
The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.

Methods Of Treating Hepatitis B Virus

View page
US Patent:
20160303095, Oct 20, 2016
Filed:
Apr 13, 2016
Appl. No.:
15/098112
Inventors:
- Foster City CA, US
Todd Appleby - San Francisco CA, US
Gabriel Birkus - Dublin CA, US
Guofeng Cheng - Foster City CA, US
David Dornan - Burlingame CA, US
Tetsuya Kobayashi - Pleasanton CA, US
Christopher Charles Mello - Sunnyvale CA, US
Uli Schmitz - Foster City CA, US
Madeleine Willkom - Foster City CA, US
Mei Yu - Foster City CA, US
International Classification:
A61K 31/44
A61K 45/06
Abstract:
The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.

Daily Task Tools That Interface With Backend Systems

View page
US Patent:
20150058752, Feb 26, 2015
Filed:
Sep 19, 2013
Appl. No.:
14/032064
Inventors:
Ingrid Bernaudin - Palo Alto CA, US
Michael Dandan - San Mateo CA, US
Steve Zyszkiewicz - San Bruno CA, US
Frank Wang - Santa Clara CA, US
Mei Yu - Palo Alto CA, US
Vidya Viswanath - San Jose CA, US
Assignee:
SUCCESSFACTORS, INC. - South San Francisco US
International Classification:
H04L 29/06
G06F 3/0488
G06F 3/0482
US Classification:
715753
Abstract:
In one embodiment, an improved computer based daily task tool is provided that interfaces with backend systems to leverage the stored information and/or processing capabilities of backend systems to provide better information and more effective task tool functionality.

Systems And Methods For Secure Storage On A Mobile Device

View page
US Patent:
20140337638, Nov 13, 2014
Filed:
May 10, 2013
Appl. No.:
13/892048
Inventors:
- South San Francisco CA, US
Mei Yu - Palo Alto CA, US
Assignee:
SUCCESSFACTORS - South San Francisco CA
International Classification:
G06F 21/60
US Classification:
713189
Abstract:
In one embodiment the present invention includes a computer-implemented method for a mobile device. An application security status is detected. When the application security status is active an application passcode is required to access functionality of a mobile application operating on the mobile device. A first encryption of data associated with the mobile application is performed, where the first encryption uses a first encryption key when the application security status is active, and the first encryption uses a second encryption key when the application security status is not active. A mobile device passcode status is detected. When the mobile device passcode status is active a mobile device passcode is required to access functionality of the mobile computing device. A second encryption of the data is performed when the mobile device passcode status is active, where the second encryption uses a third encryption key.

Hcv Genotype 6 Replicons

View page
US Patent:
20140134604, May 15, 2014
Filed:
Nov 6, 2013
Appl. No.:
14/073488
Inventors:
- Foster City CA, US
Betty Peng - London, GB
Mei Yu - San Francisco CA, US
International Classification:
C12Q 1/70
C07K 16/10
C07K 14/005
US Classification:
435 5, 536 2372, 435366, 530350, 5303894, 536 2433, 536 2432, 536 253
Abstract:
Replicons of genotype 6 hepatitis C virus (HCV) are provided. These replicons contain adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 6 replicons and methods of using these replicons to screen antiviral agents are also provided.
Control profile
Mei Xiao Yu from Oakland, CA, age ~66 Get Report